Literature DB >> 33530117

Diabetes Care During COVID-19 Pandemic in Singapore Using a Telehealth Strategy.

Xia Lian1, Rinkoo Dalan1,2, Cherng Jye Seow1, Huiling Liew1, Michelle Jong1,2, Daniel Chew1,2, Brenda Lim1, Anita Lin1, Eunice Goh1, Christina Goh1, Noorani Bte Othman1, Lucy Tan1, Bernhard O Boehm1,2.   

Abstract

Singapore currently has one of highest number of confirmed COVID-19 cases in Southeast Asia. To curb the further spread of COVID-19, Singapore government announced a temporary nationwide lockdown (circuit breaker). In view of restrictions of patients' mobility and the enforcement of safe distancing measures, usual in-person visits were discouraged. Here we describe how diabetes care delivery was ad hoc redesigned applying a telehealth strategy. We describe a retrospective assessment of subjects with diabetes, with and without COVID-19 infection, during the circuit breaker period of 7th April to 1st June 2020 managed through Tan Tock Seng Hospital's telehealth platform. The virtual health applications consisted of telephone consultations, video telehealth visits via smartphones, and remote patient monitoring. The TTSH team intensively managed 298 diabetes patients using a telehealth strategy. The group comprised of (1) 84 inpatient COVID-19 patients with diabetes who received virtual diabetes education and blood glucose management during their hospitalisation and follow-up via phone calls after discharge and (2) 214 (n=192 non-COVID; n=22 COVID-positive) outpatient subjects with suboptimal glycaemic control who received intensive diabetes care through telehealth approaches. Remote continuous glucose monitoring was applied in 80 patients to facilitate treatment adjustment and hypoglycaemia prevention. The COVID-19 pandemic situation mooted an immediate disruptive transformation of healthcare processes. Virtual health applications were found to be safe, effective and efficient to replace current in-person visits. Thieme. All rights reserved.

Entities:  

Year:  2021        PMID: 33530117     DOI: 10.1055/a-1352-5023

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Under COVID-19 Pandemic: A Quasi-Experimental Trial of Observation on Diabetes Patients' Health Behavior Affected by the Pandemic From a Coaching Intervention Program.

Authors:  Ching-Ling Lin; Li-Chi Huang; Yao-Tsung Chang; Ruey-Yu Chen; Shwu-Huey Yang
Journal:  Front Public Health       Date:  2021-05-14

2.  Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand: A real-worldexperience.

Authors:  Tasma Harindhanavudhi; Chatvara Areevut; Taninee Sahakitrungruang; Thipaporn Tharavanij; Pongtorn Kietdumrongwong; Orasa Ngimruksa; Patitta Songsiri; Siwadon Pitukweerakul; Nattamon Tanathornkirati; Natthapon Kaewprasert; Ruchirek Thamcharoen; Krittadhee Karndumri; Sunee Saetung; Pimjai Anthanont; Pornpimol Kiattisakthavee; Sarapee Putkong; Phawinpon Chotwanvirat; Chorthip Nartsupha Phattanasri; Srikorn Jinadit; Sira Korpaisarn; Manusvinee Chusane; Rattanapan Samittarucksa; Amornpan Lertrit; Sanguansak Siangruangsang; Kanokporn Sanpawithayakul; Waraporn Sathiravikarn; Sataporn Soisuwan; Parawee Chevaisrakul; Kanokporn Imsakul; Pinradakarn Thuptimtong; Jandanee Sakmanarit; Supaporn Somwang; Hussamon Prasartkaew; Ratanaporn Jerawatana; Siriwan Butadej; Porntip Tachanivate; Wallaya Jongjaroenprasert; Jeeraphan Sripatong; Sunanta Chobtangsilp; Pattraphorn Kamnirdsittiseree; Benjaporn Savetkairop; Warot Manosittisak; Jitra Tantivatanasatien; Amornrat Hathaidechadusadee; Sirimon Reutrakul
Journal:  J Diabetes Investig       Date:  2022-04-25       Impact factor: 3.681

3.  Changes in dementia diagnoses in Sweden during the COVID-19 pandemic.

Authors:  Michael Axenhus; Sophia Schedin-Weiss; Lars Tjernberg; Anders Wimo; Maria Eriksdotter; Gustaf Bucht; Bengt Winblad
Journal:  BMC Geriatr       Date:  2022-04-26       Impact factor: 4.070

4.  Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.

Authors:  Ana Palanca; Carmen Quinones-Torrelo; Juan Girbés; José T Real; F Javier Ampudia-Blasco
Journal:  Eur J Clin Invest       Date:  2022-03-27       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.